SEI Investments’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-60,131
Closed -$80.6K 3405
2026
Q1
$80.6K Buy
+60,131
New +$120K ﹤0.01% 3129
2023
Q4
Sell
-94,249
Closed -$1.24M 2676
2023
Q3
$1.24M Sell
94,249
-119,892
-56% -$2.19M ﹤0.01% 1814
2023
Q2
$5.48M Buy
214,141
+30,124
+16% +$778K 0.01% 1156
2023
Q1
$4.64M Buy
+184,017
New +$4.32M 0.01% 1224
2022
Q4
Sell
-28,282
Closed -$624K 2677
2022
Q3
$624K Sell
28,282
-649
-2% -$12.6K ﹤0.01% 1986
2022
Q2
$415K Buy
+28,931
New +$487K ﹤0.01% 2178

Other funds holding TMCI

SEI Investments's TMCI Position: Q2 2026 in Review

SEI Investments sold out of Treace Medical Concepts (TMCI) in Q2 2026, closing a stake of 60,131 shares — an estimated $80.6K sold.

SEI Investments first reported a position in TMCI in Q2 2022 and held it in 6 quarters. The position peaked at $5.48M in Q2 2023. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • SEI Investments reported no remaining Treace Medical Concepts position as of Q2 2026 after selling out during the quarter.
  • SEI Investments sold 60,131 Treace Medical Concepts shares in Q2 2026, an estimated $80.6K.
  • SEI Investments first reported a position in Treace Medical Concepts in Q2 2022 and held it in 6 quarters.
  • SEI Investments's Treace Medical Concepts position peaked at $5.48M in Q2 2023.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.